Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera

Adham Jurdi

CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer

CRITICS-II Trial

Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma

Highlights from ASCO GI 2026 by Wafik El-Deiry

ASCO GI 2026

CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma

CheckMate 9DW

Oncology News, Insights, Stories by OncoDaily

OncoCalendar

2nd Australasian International Breast Congress (AIBC)

World Congress on Controversies in Breast Cancer (CoBrCa)

08 Oct
AIBC

Drug Discovery USA 2026

European Laboratory Research and Innovation Group (ELRIG)

16 Jun
Drug Discovery USA

Emirates Digestive Diseases Week 2026

Emirates Digestive Diseases Week (EDDW)

27 Mar
Emirates Digestive Diseases Week

SEER-MHOS 2026 Update: Your Guide to the New Data Linkage

NCI Division of Cancer Control and Population Sciences

15 Jan
SEER-MHOS 2026

AMSTRO 2026 Global Oncology Conference

Asia and Middle East Society for Radiation Therapy and Oncology (AMSTRO)

06 Feb
AMSTRO 2026

OncoDaily Medical Journal